Envestnet Asset Management
MXCT icon

Envestnet Asset Management’s MaxCyte MXCT Stock Holding History

Envestnet Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,845
Closed -$28K – 4608
2025
Q2 		$28K Buy
12,845
+499
+4% +$1.21K ﹤0.01% 4403
2025
Q1 		$33.7K Sell
12,346
-3,215
-21% -$12.7K ﹤0.01% 4315
2024
Q4 		$64.7K Sell
15,561
-2,107
-12% -$7.96K ﹤0.01% 4248
2024
Q3 		$68.7K Buy
17,668
+2,426
+16% +$10.2K ﹤0.01% 4160
2024
Q2 		$59.7K Sell
15,242
-1,296
-8% -$5.58K ﹤0.01% 4095
2024
Q1 		$69.3K Buy
16,538
+1,417
+9% +$6.65K ﹤0.01% 4089
2023
Q4 		$71.1K Buy
15,121
+381
+3% +$1.48K ﹤0.01% 3971
2023
Q3 		$46K Buy
+14,740
New +$59.3K ﹤0.01% 3944

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Envestnet Asset Management's MXCT Position: Q3 2025 in Review

Envestnet Asset Management sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 12,845 shares — an estimated $28K sold.

Envestnet Asset Management first reported a position in MXCT in Q3 2023 and held it in 8 quarters. The position peaked at $71.1K in Q4 2023. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Envestnet Asset Management reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 12,845 MaxCyte shares in Q3 2025, an estimated $28K.
  • Envestnet Asset Management first reported a position in MaxCyte in Q3 2023 and held it in 8 quarters.
  • Envestnet Asset Management's MaxCyte position peaked at $71.1K in Q4 2023.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.